Panagiotis Pavlou

7PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseNutrigenomics and personalised nutritionPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Immune checkpoint inhibitor-induced diabetes mellitus: A case series from a large tertiary centre in the UK.

|Apr 29, 2026
An informatics-based data-led prioritization strategy to facilitate objective and equitable care for an ethnically diverse urban cohort of people with type 1 diabetes: A proof-of-concept study.

|Mar 19, 2026
Impact of Body Mass Index Variability on Kidney Disease Progression in a Large Type 1 Diabetes Cohort.

Murat Ozdede, Panagiotis Pavlou, Marta Avataneo

|Feb 18, 2026
Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trial.

Nikolaos Fountoulakis, Panagiotis Pavlou, Dimitra Stathi

|Jan 29, 2026
Exocrine Pancreatic Insufficiency Manifesting Before Insulin Dependence in Adult-Onset Type 1 Diabetes.

Panagiotis Pavlou, Shrawan Pandit, Janaka Karalliedde

|Jan 27, 2026
Discordant real-world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter.

Panagiotis Pavlou, Ananthi Anandhakrishnan, Kleoniki I Athanasiadou

Pageof 2

Frequent Collaborators

3 joint publications

Janaka Karalliedde

1 joint publications

Sufyan Hussain

1 joint publications

Kleoniki I Athanasiadou

1 joint publications

Yuk-Fun Liu